Emerging drugs for the management of cancer treatment induced bone loss

Author： Bertoldo Francesco   Pancheri Serena   Zenari Sonia   Boldini Stefania  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.15, Iss.2, 2010-06, pp. : 323-342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Management of Cancer Treatment-Induced Bone Loss: Considerations for Elderly Patients

By Tipples Karen   Robinson Anne  

Drugs & Aging, Vol. 28, Iss. 11, 2011-11 ,pp. : 867-883

Adis International

Access to resources Recommend Favorite

Background to and Management of Treatment-Related Bone Loss in Prostate Cancer

By Berruti A.  

Drugs & Aging, Vol. 19, Iss. 12, 2002-01 ,pp. : 899-910

Adis International

Access to resources Recommend Favorite

Emerging drugs for the treatment of pancreatic cancer

By Van Laethem Jean-Luc   Marechal Raphael  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 301-311

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in the treatment of pancreatic cancer

By Mahalingam Devalingam   Kelly Kevin R   Swords Ronan T   Carew Jennifer   Nawrocki Steffan T   Giles Francis J  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 311-328

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in the treatment of advanced gastric cancer

By Tetzlaff Eric D   Cen Putao   Ajani Jaffer A  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 135-144

Informa Healthcare

Access to resources Recommend Favorite